May 18, 2023
1:125
For every 125 shares held, investors received 1. The price per share adjusted from $0.01 to $0.00.
The split itself did not change the total investment value.
Evofem Biosciences, Inc. (EVFM) trades on the Other OTC in the Biotechnology industry.
Evofem Biosciences, Inc. company overviewThe latest split shown was on May 18, 2023. It was a 1-for-125 reverse split, so shareholders received 1 share for every 125 they held.
This history records 3 reverse splits between January 18, 2018 and May 18, 2023.